BGM Group Ltd. (BGM), a key player in China’s healthcare landscape, operates primarily within the specialty and generic drug manufacturing industry. Despite a promising market cap of $1.84 billion and..
Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering player in the biotechnology sector, is making waves with its groundbreaking immune medicine platform. Headquartered in Seattle, Washington, this commercial-stage company is spearheading..
Kymera Therapeutics, Inc. (NASDAQ: KYMR) is attracting significant interest from investors and analysts alike with its innovative approach to drug development in the biotechnology sector. The company, headquartered in Watertown,..
Investors eyeing the healthcare sector might find Bausch Health Companies Inc. (NYSE: BHC) an intriguing proposition. With a market cap of $2.37 billion, this Canadian specialty and generic drug manufacturer..
Clover Health Investments, Corp. (NASDAQ: CLOV) is making waves in the healthcare sector, particularly within the healthcare plans industry. With its innovative approach to Medicare Advantage plans, Clover Health is..
Vericel Corporation (NASDAQ: VCEL) is capturing the attention of investors in the biotechnology sector with its promising potential upside of 39.6%, based on its recent analyst ratings. Headquartered in Cambridge,..
Janux Therapeutics, Inc. (NASDAQ: JANX) is capturing the attention of investors with its promising potential upside of 185.06%, according to recent analyst ratings. This San Diego-based biotechnology firm specializes in..
Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, has been catching the eye of investors with its robust growth metrics and a promising potential upside. Based..
DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector specializing in medical instruments and supplies, has recently caught the attention of investors due to its notable potential..
Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector with a compelling growth narrative and a significant potential upside. As a commercial-stage biotechnology company, Immunocore is pioneering immunotherapies..
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is captivating investor interest with its substantial growth potential, as highlighted by an impressive 174% potential upside. Positioned in the healthcare sector, BioCryst specializes in..
Haemonetics Corporation (NYSE: HAE) stands as a prominent player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.3 billion, this Boston-based company has..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is capturing investor attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.58 billion, the company stands out as..
Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is generating considerable buzz among investors thanks to its promising 32.42% potential upside. Specializing in health information..
Organon & Co. (OGN) is an intriguing player in the healthcare sector, particularly within the general drug manufacturing industry. With a market cap of $2 billion, this Jersey City-headquartered company..
Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, has caught the attention of investors with its significant potential upside. Headquartered in Suzhou, China, the company is..
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is capturing the attention of investors with a promising 57.82% potential upside, according to analyst ratings. As a biotechnology company specializing in precision medicine oncology,..
LivaNova PLC (NASDAQ: LIVN) stands out in the healthcare sector, specifically within the medical devices industry, where it designs and delivers innovative solutions for neurological and cardiac conditions. Headquartered in..
AtriCure, Inc. (NASDAQ: ATRC), an innovative player in the healthcare sector, stands at an intriguing juncture for investors, with a market capitalization of $1.59 billion. Specializing in medical instruments and..
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a leading entity in the biotechnology sector, has recently captured the attention of investors with its compelling growth prospects and promising pipeline. Headquartered in..
